Everolimus

Anti-Caveolin-1 is developed in rabbit using a synthetic peptide corresponding to a region at the N-terminus of human caveolin-1 conjugated to keyhole limpet hemocyanin (KLH) as immunogen. Caveolin-1 (CAV1) is a multifunctional scaffolding protein,

Caveolin, a 20-24 kDa integral transmembrane protein, has been identified as a principal component of caveolae membranes. Caveolin (also termed VIP21) exists in several isoforms termed caveolin-1, caveolin-2 and caveolin-3.

Immunogen paraneoplastic Ma antigen family-like 2 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

Everolimus (RAD001), a derivative of rapamycin, is commonly used as a drug for the inhibition of the mTOR pathway, affecting tumor cell division and angiogenesis. Application Everolimus may be used as a standard in the following clinical studies:

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Everolimus, sold under trade names including Zortress &#174 , Certican, and Afinitor &#174 , is an immunosuppressant drug used to prevent rejection of organ transplants and to treat renal cell cancer and other tumors. This Certified Spiking

PrEST Antigen ARMC1 armadillo repeat containing 1, 100ul UN

PrEST Antigen ARMC4 armadillo repeat containing 4, 100ul UN

PrEST Antigen CKAP2L cytoskeleton associated protein 2-like,

PrEST Antigen CKAP2L cytoskeleton associated protein 2-like,

PrEST Antigen CKAP2L cytoskeleton associated protein 2-like,

PrEST Antigen LAMTOR2 late endosomal/lysosomal adaptor, MAPK